Communication, recruitment and enrolment in the preventative and therapeutic phase i clinical trial against HIV/AIDS based on the recombinant HIV-1 Tat protein

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 23, Issue 8, 2011, Pages 939-946

  Luzi, Anna Maria ^a   Gallo, Pietro ^a   Colucci, Anna ^a   Marcotullio, Simone ^b   Bellino, Stefania ^a   Longo, Olimpia ^a   Ensoli, Barbara ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b Nadir Onlus Foundation   (Italy)

Author keywords

clinical trials; enrolment procedures; HIV; Tat; telephone HIV AIDS counselling AIDS Help Line

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; PLACEBO; TRANSACTIVATOR PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; EDUCATIONAL STATUS; EMPLOYMENT STATUS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION PREVENTION; INFORMATION SERVICE; INTERPERSONAL COMMUNICATION; INTERVIEW; ITALY; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MASS MEDIUM; MOTIVATION; NEEDS ASSESSMENT; PATIENT COUNSELING; PATIENT IDENTIFICATION; PATIENT SELECTION; PRIORITY JOURNAL; SOCIAL PARTICIPATION; TELEPHONE; VACCINATION; VOLUNTEER; VOLUNTEER RECRUITMENT;

ADOLESCENT; ADULT; AIDS VACCINES; CLINICAL TRIALS AS TOPIC; COMMUNICATION; DOUBLE-BLIND METHOD; FEMALE; GENE PRODUCTS, TAT; HIV INFECTIONS; HIV-1; HOTLINES; HUMANS; ITALY; MALE; MIDDLE AGED; MOTIVATION; PATIENT COMPLIANCE; PATIENT PARTICIPATION; PATIENT SELECTION; PLACEBOS; YOUNG ADULT;

EID: 79960633754     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540121.2010.542124     Document Type: Article

References (18)

1. Baigis, J., Francis, M.E., & Hoffman, M. (2003). Costeffectiveness analysis of recruitment strategies in a community-based intervention study of HIV-infected persons. AIDS Care, 15, 717-728. (Pubitemid 37193861)
2. Bellino, S., Francavilla, V., Longo, O., Tripiciano, A., Paniccia, G., Arancio, A., Ensoli, B. (2009). Parallel conduction of the phase I preventive and therapeutic trials based on the Tat vaccine candidate. Review of Recent Clinical Trials, 4, 195-204.
3. Bellotti, G.G., & Bellani, M.L. (1997). Il counseling nellinfezione da HIV e nellAIDS [Counselling in the HIV infection and AIDS] (pp. 649-666). Milan: McGraw-Hill.
4. Buchbinder, S.P., Metch, B., Holte, S.E., Scheer, S., Coletti, A., & Vittinghoff, E. (2004). Determinants of enrollment in a preventive HIV vaccine trial: Hypothetical versus actual willingness and barriers to participation. Journal of Acquired Immune Deficiency Syndrome, 36, 604-612. (Pubitemid 38544510)
5. Caputo, A., Gavioli, R., Bellino, S., Longo, O., Tripiciano, A., Francavilla, V., Ensoli, B. (2009). HIV-1 Tatbased vaccines: an overview and perspectives in the field of HIV/AIDS vaccine development. International Reviews of Immunology, 28, 285-334.
6. Colfax, G., Buchbinder, S., Vamshidar, G., Celum, C., McKirnan, D., Neidig, J., Bartholow, B. (2005). Motivations for participating in an HIV vaccine efficacy trial. Journal of Acquired Immune Deficiency Syndrome, 39, 359-364. (Pubitemid 40923219)
7. de Mei, B, Luzi, A.M., & Gallo, P. (1998). Proposta per un percorso formativo sul counselling integrato. Annales. Istituto Superiore di Sanita, 34, 529-539.
8. Ensoli, B., Fiorelli, V., Ensoli, F., Cafaro, A., Titti, F., Butto, S., & Garaci, E. (2006). Candidate HIV-1 Tat vaccine development: From basic science to clinical trials. AIDS, 20, 2245-2261. (Pubitemid 44789527)
9. Ensoli, B., Fiorelli, V., Ensoli, F., Lazzarin, A., Visintini, R., Narciso, P., & Garaci, E. (2008). The therapeutic phase I trial of the recombinant native HIV-1 Tat protein. AIDS, 22, 2207-2209.
10. Gross, C.P., Mallory, R., Heiat, A., & Krumholz, H.M. (2002). Reporting the recruitment process in clinical trials: Who are these patients and how did they get there? Annals of Internal Medicine, 137, 10-16. (Pubitemid 34705371)
11. Haidich, A.B., & Ioannidis, J.P. (2001). Patterns of patient enrollment in randomized controlled trials. Journal of Clinical Epidemiology, 54, 877-883. (Pubitemid 32755779)
12. Halpern, S.D., Metzger, D.S., Berlin, J.A., & Ubel, P.A. (2001). Who will enroll? Predicting participation in a phase II AIDS vaccine trial. Journal of Acquired Immune Deficiency Syndrome, 27, 281-288. (Pubitemid 32661971)
13. Longo, O., Tripiciano, A., Fiorelli, V., Bellino, S., Scoglio, A., Collacchi, B., Ensoli, B. (2009). Phase I therapeutic trial of the HIV-1 Tat protein and long term follow-up. Vaccine, 27, 3306-3312.
14. Mills, E., Wilson, K., Rachlis, B., Griffith, L., Wu, P., Guyatt, G., & Cooper, C. (2006). Barriers to participation in HIV drug trials: A systematic review. Lancet Infectious Disease, 6, 32-38. (Pubitemid 41831375)
15. Sheon, A.R., Wagner, L., McElrath, M.J., Keefer, M.C., Zimmerman, E., Israel, H., Fast, P. (1998). Preventing discrimination against volunteers in prophylactic HIV vaccine trials: Lessons from a phase II trial. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 19, 519-526.
16. Silverman, W.A., & Altman, D.G. (1996). Patients preferences and randomised trials. Lancet, 347, 171-174.
17. Starace, F., Wagner, T.M., Luzi, A.M., Cafaro, L., Gallo, P., & Rezza, G. (2006). Knowledge and attitudes regarding preventative HIV vaccine clinical trials in Italy: Results of a national survey. AIDS Care, 18, 66-72. (Pubitemid 43154675)
18. Thapinta, D., Jenkins, R.A., Morgan, P.A., Chiu, J., Boenim, W., Bussaratid, V., Thongchareon, P. (2002). Recruiting volunteers for a multisite phase I/II HIV preventive vaccine trial in Thailand. Journal of Acquired Immune Deficiency Syndrome, 30, 503-513.